Eli Lilly's (LLY) sees a 60% sales jump from April to May in India for its obesity/ diabetes drug Mounjaro. Read more here.

The Nutraceutical Packaging Market is witnessing steady growth driven by rising health awareness and demand for functional foods. Key players such as ...

Driven by self-medication trends, health-conscious consumers, and innovative formulations, the OTC drugs market thrives on the widespread availabilit ...

A part-time MBA student reflects on how attending the 2025 India Business Conference highlighted the country’s growing global ...

The Asia Pacific healthcare augmented reality (AR) and virtual reality (VR) market is set to grow significantly, with an anticipated annual growth rate of 36.2%, reaching a total market cap of $70.15 ...

Practo, an Indian healthcare services platform connecting doctors and patients, wants to double its revenue from international business in the next three years as it expands into developed markets, a ...

“While we do not expect a material immediate impact on the US generics business of Indian pharma companies, its revenue growth and capital allocation strategies may likely be impacted, if the ...

Further, India’s pharma industry is also more diversified compared to China’s, with a strong foothold in generics, biotech, and biosimilars. While we discussed the growth of the CDMO industry ...

"The Indian pharmaceutical industry plays a vital role in ensuring access to affordable, quality-assured medicines in the US,” says Sudarshan Jain, secretary general, Indian Pharmaceutical ...

As Novartis navigates the complex landscape of the pharmaceutical industry, it faces both significant opportunities and challenges that warrant a closer examination. Novartis has established ...

Despite the Indian pharmaceutical industry's notable achievements on the global stage, it lags behind its international counterparts in adopting robust ESG practices. A literature review has ...

One of the key challenges facing Novartis, along with the broader pharmaceutical industry, is the evolving regulatory landscape, particularly concerning drug pricing. The impact of the Inflation ...